We described that CTLA-4 might regulate tumor immune microenvironment by enhancing relevant immunomodulators, such as IL-15 and CSF-1, which prime NK and M1 macrophages, two cells interconnected by their immunomodulatory functions. The gene discussed is CSF1; the disease is neoplasm.